Neil James Clendeninn Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Neil James Clendeninn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Neil James Clendeninn. Neil James Clendeninn is SVP & Chief Medical Officer in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and Director in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI).
Latest Insider Trading Transactions of Neil James Clendeninn
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2016 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 1.00 | 22,500 | 22,500 | 22,500 | |
| May 24 2016 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| May 24 2016 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 0.00 | 2,500 | 0 | 22,421 | 19.9 K to 22.4 K (+12.55 %) |
| Oct 30 2015 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 2.69 | 5,359 | 14,416 | 0 | |
| Oct 30 2015 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 2.69 | 5,359 | 14,416 | 19,921 | 14.6 K to 19.9 K (+36.80 %) |
| Oct 13 2015 | HRTX | HERON THERAPEUTICS ... | Clendeninn Neil James | SVP & Chief Medical ... | Option Exercise | A | 28.30 | 50,000 | 1,415,000 | 50,000 | |
| Oct 13 2015 | HRTX | HERON THERAPEUTICS ... | Clendeninn Neil James | SVP & Chief Medical ... | Option Exercise | A | 28.30 | 100,000 | 2,830,000 | 100,000 | |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 1.89 | 5,000 | 9,450 | 5,000 | |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 0.00 | 2,500 | 0 | 14,562 | 12.1 K to 14.6 K (+20.73 %) |
| Jun 09 2014 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
| Jun 09 2014 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 3.62 | 5,000 | 18,100 | 5,000 | |
| Jun 09 2014 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| Jun 09 2014 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 0.00 | 2,500 | 0 | 12,062 | 9.6 K to 12.1 K (+26.15 %) |
| May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
| May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 10.73 | 5,000 | 53,650 | 5,000 | |
| May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 0.00 | 2,000 | 0 | 0 | |
| May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 10.64 | 2,000 | 21,280 | 9,562 | 7.6 K to 9.6 K (+26.45 %) |
| Oct 19 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 4.11 | 513 | 2,106 | 0 | |
| Oct 19 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 4.11 | 513 | 2,106 | 7,562 | 7 K to 7.6 K (+7.28 %) |
| Aug 07 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 4.11 | 3,702 | 15,197 | 0 | |
| Aug 07 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 4.11 | 3,702 | 15,197 | 7,049 | 3.3 K to 7 K (+110.61 %) |
| Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
| Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 12.56 | 4,000 | 50,240 | 4,000 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 18.94 | 3,046 | 57,686 | 3,046 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 4.11 | 513 | 2,107 | 513 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 4.11 | 3,699 | 15,194 | 3,699 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 3.89 | 952 | 3,705 | 952 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 3.89 | 2,393 | 9,312 | 2,393 |
Page: 1